Organogenesis Holdings Inc. SEC filings ORGO
Organogenesis Holdings Inc. has 673 filings in SEC EDGAR's recent list, going back to Dec 18, 2015. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Apr 30, 2026 | Jun 15, 2026 |
| DEF 14A | Proxy statement | May 12, 2025 | Jun 23, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 29, 2025 | Jun 23, 2025 |
| DEF 14A | Proxy statement | Apr 29, 2024 | Jun 20, 2024 |
| DEF 14A | Proxy statement | May 1, 2023 | — |
| DEF 14A | Proxy statement | May 10, 2022 | Jun 23, 2022 |
| PRE 14A | Preliminary proxy statement | Apr 29, 2022 | Jun 23, 2022 |
| DEF 14A | Proxy statement | Nov 30, 2021 | Dec 29, 2021 |
| DEF 14A | Proxy statement | Nov 20, 2020 | Dec 18, 2020 |
| DEF 14A | Proxy statement | Jul 22, 2019 | Jul 22, 2019 |
| PRE 14A | Preliminary proxy statement | Jul 12, 2019 | Jul 12, 2019 |
| DEF 14A | Proxy statement | Sep 12, 2018 | Oct 4, 2018 |
| PRE 14A | Preliminary proxy statement | Aug 21, 2018 | Aug 21, 2018 |
| DEF 14A | Proxy statement | May 31, 2018 | Jun 28, 2018 |
| DEFA14A | Additional proxy material | Nov 22, 2017 | — |
| DEFA14A | Additional proxy material | Aug 22, 2017 | — |
| DEFA14A | Additional proxy material | Aug 22, 2017 | — |
| DEFA14A | Additional proxy material | Aug 21, 2017 | — |
Showing 18 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ORGO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Canton, MA
- SEC filer status
- Accelerated filer
- SEC CIK
- 1661181
- Former names
- Avista Healthcare Public Acquisition Corp. (until Dec 10, 2018)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.